{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:40:19Z","timestamp":1784335219648,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminoncol.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1053\/j.seminoncol.2017.12.001","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T17:07:08Z","timestamp":1515258428000},"page":"428-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma"],"prefix":"10.1053","volume":"44","author":[{"given":"Colleen S.","family":"Curran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2017.12.001_bib1","series-title":"Gastroenterology","author":"Heuman","year":"1997"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.15.578","article-title":"Hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"15","author":"Teufel","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/2327-6924.12055","article-title":"Autoimmune hepatitis: a noninfectious killer","volume":"26","author":"Ferguson","year":"2014","journal-title":"J Am Assoc Nurse Pract"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","article-title":"Diagnostic criteria of autoimmune hepatitis","volume":"13","author":"Liberal","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2017.12.001_bib7","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/modpathol.3800684","article-title":"Autoimmune liver disease: overlap and outliers","volume":"20","author":"Washington","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib8","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.3748\/wjg.v17.i28.3322","article-title":"Immunostaining of PD-1\/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma","volume":"17","author":"Wang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1572-0241.2006.00948.x","article-title":"Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases","volume":"102","author":"Mataki","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.20488","article-title":"Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice","volume":"40","author":"Yu","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib11","doi-asserted-by":"crossref","first-page":"G237","DOI":"10.1152\/ajpgi.00371.2015","article-title":"Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis","volume":"311","author":"Wang","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365521.2016.1233576","article-title":"Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis","volume":"52","author":"Aarslev","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-006-9022-6","article-title":"Matrix metalloproteinase-9 and autoimmune diseases","volume":"26","author":"Ram","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteinases in liver injury, repair and fibrosis","volume":"44-46","author":"Duarte","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib15","doi-asserted-by":"crossref","first-page":"e66604","DOI":"10.1371\/journal.pone.0066604","article-title":"Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases","volume":"8","author":"Qi","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib17","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.4049\/jimmunol.1402550","article-title":"NF-kappaB regulates PD-1 expression in macrophages","volume":"194","author":"Bally","year":"2015","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2006-10-051482","article-title":"Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway","volume":"110","author":"Liu","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1189\/jlb.0113051","article-title":"Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1","volume":"94","author":"Hutchins","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1827.2007.02129.x","article-title":"Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease","volume":"57","author":"Oikawa","year":"2007","journal-title":"Pathol Int"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaut.2011.02.009","article-title":"Programmed death-1 is required for systemic self-tolerance in newly generated T cells during the establishment of immune homeostasis","volume":"36","author":"Thangavelu","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib22","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/eji.201344423","article-title":"PD-1 regulates extrathymic regulatory T-cell differentiation","volume":"44","author":"Chen","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","article-title":"T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile","volume":"41","author":"Longhi","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/liv.12245","article-title":"Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis","volume":"34","author":"Ma","year":"2014","journal-title":"Liver Int"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jgh.12340","article-title":"Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis","volume":"29","author":"Matsumoto","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/xen.12261","article-title":"Inhibition of B-cell activation and antibody production by triggering inhibitory signals via the PD-1\/PD-ligand pathway","volume":"23","author":"Buermann","year":"2016","journal-title":"Xenotransplantation"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib28","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/hep.27991","article-title":"Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells","volume":"62","author":"Beland","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.27087","article-title":"Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice","volume":"60","author":"Ikeda","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2249.2000.01356.x","article-title":"Serum interferon-gamma-inducing factor\/IL-18 levels in primary biliary cirrhosis","volume":"122","author":"Yamano","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s40064-016-2512-y","article-title":"Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis","volume":"5","author":"Abe","year":"2016","journal-title":"Springerplus"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.febslet.2004.05.039","article-title":"The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells","volume":"569","author":"Ishida","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18, more than a Th1 cytokine","volume":"25","author":"Novick","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1086\/654932","article-title":"Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis","volume":"202","author":"Alvarez","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clim.2010.08.013","article-title":"The simultaneous high expression of Valpha24, IFN-gamma and FoxP3 characterizes the liver of children with type I autoimmune hepatitis","volume":"137","author":"Ferreyra Solari","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib36","doi-asserted-by":"crossref","first-page":"e0146086","DOI":"10.1371\/journal.pone.0146086","article-title":"Exploring the role of killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis","volume":"11","author":"Littera","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2012.05.006","article-title":"Regulatory NK cells in autoimmune disease","volume":"39","author":"Tian","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1189\/jlb.5RU0714-360RR","article-title":"Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP","volume":"97","author":"Fabbi","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib39","first-page":"264","article-title":"Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus","volume":"21","author":"Migliorini","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jim-2016-000301","article-title":"Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjogren's syndrome","volume":"65","author":"Liuqing","year":"2017","journal-title":"J Investig Med"},{"issue":"suppl","key":"10.1053\/j.seminoncol.2017.12.001_bib41","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population","volume":"47","author":"Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib42","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis","volume":"14","author":"Gomaa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib43","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.27867","article-title":"Myeloid cells in hepatocellular carcinoma","volume":"62","author":"Wan","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib44","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1158\/0008-5472.CAN-09-0901","article-title":"Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1\/programmed death-1 interactions","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/mc.20664","article-title":"Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis","volume":"49","author":"He","year":"2010","journal-title":"Mol Carcinog"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.27492","article-title":"Axl activates autocrine transforming growth factor-beta signaling in hepatocellular carcinoma","volume":"61","author":"Reichl","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib47","doi-asserted-by":"crossref","first-page":"e0154767","DOI":"10.1371\/journal.pone.0154767","article-title":"Axl expression stratifies patients with poor prognosis after hepatectomy for hepatocellular carcinoma","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib48","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib49","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.28419","article-title":"CD14(+) regulatory dendritic cells in patients with hepatocellular carcinoma and cirrhosis","volume":"63","author":"Tanoue","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib50","doi-asserted-by":"crossref","first-page":"e1085146","DOI":"10.1080\/2162402X.2015.1085146","article-title":"PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity","volume":"5","author":"Lim","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib51","doi-asserted-by":"crossref","first-page":"e0117458","DOI":"10.1371\/journal.pone.0117458","article-title":"Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression","volume":"10","author":"Jia","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi Identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib53","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/ijc.27535","article-title":"Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells","volume":"131","author":"Kakita","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","article-title":"Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma","volume":"66","author":"Garnelo","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib55","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/aps.2015.41","article-title":"Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy","volume":"36","author":"Sun","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib56","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","article-title":"Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","article-title":"Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients","volume":"129","author":"Cai","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib58","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/2326-6066.CIR-15-0229","article-title":"Expanded and activated natural killer cells for immunotherapy of hepatocellular carcinoma","volume":"4","author":"Kamiya","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib59","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.3748\/wjg.v13.i32.4345","article-title":"Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma","volume":"13","author":"Tangkijvanich","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib60","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4049\/jimmunol.1502301","article-title":"Characterization of the inflammasome in human Kupffer cells in response to synthetic agonists and pathogens","volume":"197","author":"Zannetti","year":"2016","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both Th1 and Th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ijc.21367","article-title":"Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection","volume":"118","author":"Asakawa","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib64","doi-asserted-by":"crossref","first-page":"G565","DOI":"10.1152\/ajpgi.00058.2011","article-title":"Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis","volume":"301","author":"Zhang","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib65","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1073\/pnas.1324140111","article-title":"Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses","volume":"111","author":"Bulau","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1189\/jlb.5RU0816-341R","article-title":"A protective role of IL-37 in cancer: a new hope for cancer patients","volume":"101","author":"Abulkhir","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib67","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1038\/srep05177","article-title":"Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells","volume":"4","author":"Zhao","year":"2014","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib68","doi-asserted-by":"crossref","first-page":"12928","DOI":"10.1074\/jbc.M700554200","article-title":"A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix","volume":"282","author":"Han","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib69","doi-asserted-by":"crossref","first-page":"e90571","DOI":"10.1371\/journal.pone.0090571","article-title":"Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis","volume":"9","author":"Calabro","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib70","doi-asserted-by":"crossref","first-page":"e95870","DOI":"10.1371\/journal.pone.0095870","article-title":"Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib71","doi-asserted-by":"crossref","first-page":"46020","DOI":"10.18632\/oncotarget.17546","article-title":"Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejca.2016.03.002","article-title":"High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis","volume":"59","author":"Finkelmeier","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2017.12.001_bib73","doi-asserted-by":"crossref","first-page":"e1091146","DOI":"10.1080\/2162402X.2015.1091146","article-title":"A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage","volume":"5","author":"Dezutter-Dambuyant","year":"2016","journal-title":"Oncoimmunology"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775417301756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775417301756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T22:40:10Z","timestamp":1660257610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775417301756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0093775417301756"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2017.12.001","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}